Notes / Company

CORONA Remedies Ltd.

CORONA BSE 544644 ISIN INE02ZQ01018 Pharmaceuticals

Fundamentals

Market cap: ₹10,246 cr
P/E: 55.35×
ROE: 24.65%
Debt / equity: 0.10
Div yield: 0.60%
52-week range: 1336.60 — 1949.40

The timeline — 1 note on CORONA Remedies Ltd.

May 2026

28 May 26 · 3:57 PM IST Lead

Lead · Mid cap

Corona Remedies wins EU-GMP approval for its Ahmedabad hormone plant

The certification allows the company to export specialized hormone products to European markets, following an inspection in April 2026.

Verify on exchange BSE filings for CORONA NSE filings for CORONA